UPDATE: Goldman Sachs Upgrades Carter's to Buy

According to Goldman Sachs, Carter's CRI is upgraded to Buy. Goldman Sachs said that it upgrades CRI to Buy from Neutral as: CRI is in the early stages of raising prices in its wholesale business (50% of sales) to offset higher input costs. “Our 6-month price target is raised to $46 (from $31) and is based on fundamental valuation (85%) of $45 (we apply CRI's historical P/E multiple of 14X to 2013 estimates and discount it back) and LBO valuation (15%) of $50.” Carter's closed yesterday at $40.16.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorUpgradesAnalyst RatingsGoldman Sachs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!